The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy

BACKGROUND: Intravenous tissue plasminogen activator (tPA) (0.9 mg/kg, maximum 90 mg) with a bolus of 10% of the total dose given within 1–2 mins is the standard therapy for patients receiving thrombolytic therapy. Low-dose (0.6 mg/kg) tPA is also approved for thrombolytic therapy for ischemic strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Yi-Sin, Sung, Sheng-Feng, Wu, Chi-Shun, Hsu, Yung-Chu, Su, Yu-Hsiang, Hung, Ling-Chien, Ong, Cheung-Ter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974114/
https://www.ncbi.nlm.nih.gov/pubmed/32021109
http://dx.doi.org/10.2147/DDDT.S235388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974114/
https://www.ncbi.nlm.nih.gov/pubmed/32021109
http://dx.doi.org/10.2147/DDDT.S235388

Ejemplares similares